Enoximone

CARDIOVASCULAR SYSTEM

Key facts

Enoximone is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1988. DrugCentral lists 2 molecular targets, including PDE4A|PDE4B|PDE4C|PDE4D and PDE3A.

• Molecular targets: PDE4A|PDE4B|PDE4C|PDE4D and PDE3A (2 listed in DrugCentral).
• ATC code: C01CE03 (Phosphodiesterase inhibitors).
• Molecular formula: C12H12N2O2S; molecular weight 248.30 g/mol.

Mechanism & targets

Molecular targets (2)

Target	Gene	Action	Activity
Phosphodiesterase 4	PDE4A|PDE4B|PDE4C|PDE4D	unknown	IC50 5.54
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	PDE3A	unknown	IC50 5.34

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
1988-01-01	YEAR INTRODUCED	—	—

ATC classification

ATC code	Therapeutic hierarchy
C01CE03	CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES › Phosphodiesterase inhibitors

Chemical structure

• Molecular formula: C₁₂H₁₂N₂O₂S
• Molecular weight: 248.30 g/mol
• CAS number: 77671-31-9
• InChIKey: ZJKNESGOIKRXQY-UHFFFAOYSA-N
• PubChem CID: 53708

CSC1=CC=C(C=C1)C(=O)C1=C(C)NC(=O)N1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Enoximone work?

Its molecular targets in DrugCentral include PDE4A|PDE4B|PDE4C|PDE4D and PDE3A.

When was Enoximone first approved?

Enoximone was first approved by the YEAR INTRODUCED in 1988.

What is the chemical formula of Enoximone?

Enoximone has the molecular formula C12H12N2O2S and a molecular weight of 248.30 g/mol.

Sources

• DrugCentral drug card 1014 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL249856 — compound record and bioactivity
• PubChem CID 53708 — chemical identifiers
• DrugBank DB04880 — drug record
• FDA UNII C7Z4ITI7L7 — substance identity
• UniProt Q14432 (PDE3A) — target protein

How this page is built: methodology · editorial policy & corrections.